Non-Invasive Prenatal Testing (NIPT)In the blood collection facility at our centre you can undergo one of non-invasive screening tests of high sensitivity (non invasive prenatal testing (NIPT). NIPT should be recognized as an element of modern first trimester screening based additionally on early anomaly scan, early fetal echocardiography, and serum PlGF sampling (for preeclampsia risk assessment). This approach replaces the traditional Combined Screening Test based on NT+Fetal Heart Rate + serum PAPP-A + sercum free-beta HCG, which shows more false positive readings than expected in Poland. in cooperation with:
- neoBona by Synlab with confirmed accuracy in clinical studies (also for the purpose of our clinical study aimed at optimisation and clinical effectiveness of first trimester screening), in case of suspicious results CVS or amniocentesis is fully refunded;
- Harmony Test from DIAGNOSTYKA with confirmed accuracy in clinical studies;
- NIFTY by BGI with confirmed accuracy in clinical studies;
- Harmony -by renowned Roche company with confirmed accuracy and wide bibliography;
- NIPT – analyses performed in Poland by European Sequencing Centre based on NGS technology, with confirmed accuracy;
- SANCO by GENOMED with confirmed accuracy in clinical studies.
Tests allow to estimate:
- the risk of fetal trisomy, such as the Down syndrome – trisomy 21 (sensitivity of 99%, false positive rate of 0.2%); Edwards’ syndrome – trisomy 18 (sensitivity of 99%); Patau syndrome (sensitivity of 79-92%, false positive rate of 1%). Presented data are independent of the distributors (according to NCHPEG);
- the risk of fetal microdeletion syndomes, e.g. 22q11 microdeletion syndrome, also called DiGeorge syndrome
- the other chromosomal aberrations risk
- prenatal baby gender test
Pricing of NIPT at our practice starts from 1800 PLN including refunding of CVS / amniocentesis in case of receiving suspicious NIPT result.
neoBona test showed the best efficiency in cases of low fetal DNA fraction to min. 1% (i.e. in high BMI patients). Link to the article on this topic. New data on NIPT.
Attention: NIPT tests cannot replace fetal karyotype assessment from chronic villus sampling, amniocentesis or fetal blood sampling and each suspicious NIPT result should be confirmed by the karyotype examiation!
NIPT limits involve:
- lower sensitivity in case of a low weight of placenta (occurs in trisomy 18 and trisomy 13), which is characterized by low levels of PAPP-A;
- situation, when a sample shows so called fetal fraction lower than 6% (which occurs more frequently in patients with an increased BMI);
- dizygotic twin pregnancy (the majority of dichorionic twin pregnancies); or singelton pregnancy being originally a twin dizygotic pregnancy with intrauterine demise of one twin;
- placental mosaicism not related with chromosomal aberration in the baby.
Attention! NIPT examination does not replace a first trimester ultrasound scan. An ultrasound scan allows to assess early fetal anatomy and exclude its major anomalies whether or not connected with genetic syndromes. This type of anomalies is highly more common than genetic syndromes and constitutes ab. 66% of all fetal problems. For comparison, the Down syndrome constitutes only 10-15% of them. If you decide on fetal evaluation of the highest standard, the best option would be to perform an ultrasound scan together with the assessment of early fetal anatomy at 12 weeks of gestation, and then to take blood samples for high sensitivity NIPT tests.
- links to information concerning NIPT testing: